Imagine an experiment measuring 3 different cancer-related genes across 4 different patient tissue samples (2 healthy controls and 2 tumor samples).
Raw sequencing machines generate wildly skewed counts. Because biological data grows exponentially, looking at raw numbers makes it impossible to see patterns. Bioinformaticians use Log2 Transformation (`np.log2`) to compress this data so it can be compared fairly.



## Output
```bash
                  [Healthy_1] [Healthy_2] [Tumor_1] [Tumor_2]
TP53 (Suppressor) [   6.92        6.86       3.70      4.00  ]  -> Switched OFF
BRCA1 (Repair)    [   5.52        5.67       5.61      5.73  ]  -> Unchanged
MYC   (Oncogene)  [   3.17        3.91       9.00      9.32  ]  -> Switched ON
```


## The Biological Insights:
1. The Overlooked Pattern: In the raw numbers, MYC jumps from 8 to 512 (a massive spike), while TP53 drops from 120 to 12 (a tiny drop numerically).
2. The Biological Reality: After the Log2 transformation, you can see that MYC increased by about 6 units (from 3.17 to 9.32), and TP53 decreased by about 3 units (6.92 to 4.00). Because this scale is logarithmic, each single integer change represents a 2-fold doubling or halving of activity - that means $\(2^6 = 64\)$, a 6-unit increase means the cancer cells are producing roughly 64 times more MYC oncogene copies than the healthy cells!
3. The Diagnosis: MYC is a known oncogene (cancer-driver). Seeing its expression jump from ~3.5 to ~9.1 indicates a catastrophic, aggressive activation characteristic of a tumor sample.

In cancer genomics, measuring mRNA levels reveals which genes are altered in tumor tissues compared to healthy ones. We use a $\(\text{Log}_{2}\)$ scale because raw gene expression numbers vary wildly (from 0 to 100,000+ copies). Converting them to $\(\text{Log}_{2}\)$ stabilizes the variance so we can easily compare them: a change from 4 to 5 means expression has doubled.

1. TP53 (Tumor Suppressor): This is the "Guardian of the Genome." In healthy cells, it is highly active (around 6.9) to prevent cancer. Its drastic drop to 3.7 in the tumor samples indicates it has been deactivated or mutated, allowing uncontrolled cell growth.
2. BRCA1 (Control/Flat): This gene is involved in DNA repair. Its flat line around 5.6 indicates stable, baseline expression across all samples, acting as a reliable comparison benchmark.
3. MYC (Oncogene): This is a cancer-promoting gene. It stays low (3.5) in healthy tissues where cell division is tightly regulated, but spikes drastically up to 9.3 in the tumors—meaning it is heavily overexpressed, driving rapid tumor proliferation.






















































